LOPHORA SUBMITS CLINICAL TRIAL AUTHORISATION (CTA) APPLICATION TO THE FRENCH MEDICINES AGENCY (ANSM) FOR LEAD CNS DRUG LPH-5. 31 May 2024
Lophora, a clinical-stage CNS drug discovery company developing novel, next generation 5HT2ARA medicines... Read more